Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer
Abroad (travel likely)Recruiting
Conditions
Locally Advanced Biliary Tract Cancers · Metastatic Biliary Tract Cancers
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, South Korea
Contact: Principal Investigator (Hong Jae Chon)
Study leads
Hong Jae Chon, MD. PhD
Principal Investigator
Principal Investigator